Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis-Reference-Cited by-同舟云学术

Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

Published:2019-10 Issue:11 Volume:17 Page:2310-2319.e6
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Pelusi Serena,Cespiati Annalisa,Rametta Raffaela,Pennisi Grazia,Mannisto Ville,Rosso Chiara,Baselli Guido,Dongiovanni Paola,Fracanzani Anna Ludovica,Badiali Sara,Maggioni Marco,Craxi Antonio,Fargion Silvia,Prati Daniele,Nobili Valerio,Bugianesi Elisabetta,Romeo Stefano,Pihlajamaki Jussi,Petta Salvatore,Valenti Luca^ORCID

Funder

Associazione italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?;Valenti;Liver Int,2016

3. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis;Tilg;Hepatology,2010

4. Genetics and epigenetics of NAFLD and NASH: clinical impact;Eslam;J Hepatol,2018

5. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between neutrophil-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease and liver fibrosis in the US population: a nationally representative cross-sectional study using NHANES data from 2017 to 2020;BMC Gastroenterology;2024-09-05

2. Current status and future trends of the global burden of MASLD;Trends in Endocrinology & Metabolism;2024-08

3. Association between cardiometabolic index and hepatic steatosis and liver fibrosis: a population-based study;Hormones;2024-06-11

4. Association of neutrophil-to-high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease and liver fibrosis: a nationally representative cross-sectional study by NHANES from 2017 to 2020;2024-05-07

5. The first MASH drug therapy on the horizon: Current perspectives of resmetirom;Liver International;2024-04-05